Xu L - Search Results

1

Recent Progress of Deep Learning in Drug Discovery.

Wang F, Diao X, Chang S, Xu L. Wang F, et al. Among authors: xu l. Curr Pharm Des. 2021;27(17):2088-2096. doi: 10.2174/1381612827666210129123231. Curr Pharm Des. 2021. PMID: 33511933

2

Unraveling the conformational determinants of LARP7 and 7SK small nuclear RNA by theoretical approaches.

Xu L, Kong R, Zhu J, Sun H, Chang S. Xu L, et al. Mol Biosyst. 2016 Jul 19;12(8):2613-21. doi: 10.1039/c6mb00252h. Mol Biosyst. 2016. PMID: 27301448

3

Exploring the molecular basis of RNA recognition by the dimeric RNA-binding protein via molecular simulation methods.

Chang S, Zhang DW, Xu L, Wan H, Hou TJ, Kong R. Chang S, et al. Among authors: xu l. RNA Biol. 2016 Nov;13(11):1133-1143. doi: 10.1080/15476286.2016.1223007. Epub 2016 Sep 3. RNA Biol. 2016. PMID: 27592836 Free PMC article.

4

Exploring the RNA-bound and RNA-free human Argonaute-2 by molecular dynamics simulation method.

Kong R, Xu L, Piao L, Zhang D, Hou TJ, Chang S. Kong R, et al. Among authors: xu l. Chem Biol Drug Des. 2017 Nov;90(5):753-763. doi: 10.1111/cbdd.12997. Epub 2017 May 12. Chem Biol Drug Des. 2017. PMID: 28388001

5

How Does the L884P Mutation Confer Resistance to Type-II Inhibitors of JAK2 Kinase: A Comprehensive Molecular Modeling Study.

Kong X, Sun H, Pan P, Li D, Zhu F, Chang S, Xu L, Li Y, Hou T. Kong X, et al. Among authors: xu l. Sci Rep. 2017 Aug 22;7(1):9088. doi: 10.1038/s41598-017-09586-3. Sci Rep. 2017. PMID: 28831147 Free PMC article.

6

Benchmark Study Based on 2P2I_DB to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.

Wang Z, Kang Y, Li D, Sun H, Dong X, Yao X, Xu L, Chang S, Li Y, Hou T. Wang Z, et al. Among authors: xu l. J Phys Chem B. 2018 Mar 8;122(9):2544-2555. doi: 10.1021/acs.jpcb.7b12658. Epub 2018 Feb 22. J Phys Chem B. 2018. PMID: 29420886

7

Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.

Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T. Chen H, et al. Among authors: xu l. ACS Chem Neurosci. 2019 Jan 16;10(1):677-689. doi: 10.1021/acschemneuro.8b00489. Epub 2018 Oct 17. ACS Chem Neurosci. 2019. PMID: 30265513

8

Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitors.

Yu J, Liu J, Li D, Xu L, Hong D, Chang S, Xu L, Li J, Liu T, Zhou Y. Yu J, et al. Among authors: xu l. Eur J Med Chem. 2019 Feb 15;164:423-439. doi: 10.1016/j.ejmech.2018.12.072. Epub 2018 Dec 31. Eur J Med Chem. 2019. PMID: 30611983

9

Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays.

Zhou W, Duan M, Fu W, Pang J, Tang Q, Sun H, Xu L, Chang S, Li D, Hou T. Zhou W, et al. Among authors: xu l. Genomics Proteomics Bioinformatics. 2018 Dec;16(6):416-427. doi: 10.1016/j.gpb.2018.03.007. Epub 2019 Jan 9. Genomics Proteomics Bioinformatics. 2018. PMID: 30639122 Free PMC article.

10

A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.

Zhang DW, Luo RH, Xu L, Yang LM, Xu XS, Bedwell GJ, Engelman AN, Zheng YT, Chang S. Zhang DW, et al. Among authors: xu l, xu xs. Antiviral Res. 2019 Sep;169:104544. doi: 10.1016/j.antiviral.2019.104544. Epub 2019 Jun 27. Antiviral Res. 2019. PMID: 31254557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,539 results

Search Page

Filters